Category: US MSOs
-
Marijuana update: Where the blood runs hard, look for the guys with swords
“There are times […] when even being right feels wrong. What do you say, for instance, about a generation that has been taught that rain is poison and sex is death? If making love might be fatal and if a cool spring breeze on any summer afternoon can turn a crystal blue lake into a…
-
Cannabis corner: Chemesis (CSI.C) signs $6M deal, Khiron (KHRN.V) eyes greater EU-LatAm trade and iAnthus (IAN.C) deepens Florida roots
Chemesis International (CSI.C) subsidiary, Natural Ventures, has signed a three year, USD$6M minimum purchase agreement with PR ONE, a medical cannabis company based in Puerto Rico. Over the deal’s three-year lifespan, PR ONE has signed on to purchase a minimum of $300,000 of cannabis infused products and a minimum of $200,000 of flower monthly from Chemesis’…
-
Fundamental hype: As US MSO’s struggle, is National Access Cannabis (META.V) building the Canadian alternative?
About eighteen months ago, National Access Cannabis (META.V) emerged as part II of the Chuck Rifici master plan of Canadian weed v2.0 domination. His v1.0 domination plan was a company called Tweed, which later became Canopy Growth Corp (WEED.T). At a current $19.5 billion market cap, I guess you’d call that one a win, but…
-
iAnthus (IAN.C) retools stock option plan: Pitchforks and torches lowered as shorts bail
Sunlight is the best disinfectant, or so the old saying goes, meaning it’s only when bad things are exposed that bad things are corrected. US multi-state dispensary operator iAnthus (IAN.C), it seems, is soaking up the rays today. Hadley Ford, chief executive officer of iAnthus, stated: “We have cancelled recent option grants to members of…
